| Hina Aziz Rehman, MD | |
|
1401 W Pulaski St, Fort Worth, TX 76104-2717 | |
| (682) 885-8012 | |
| (682) 885-8014 |
| Full Name | Hina Aziz Rehman |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1401 W Pulaski St, Fort Worth, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003263138 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | S1692 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hina Aziz Rehman, MD Po Box 99213, Fort Worth, TX 76199-0213 Ph: (682) 885-1860 | Hina Aziz Rehman, MD 1401 W Pulaski St, Fort Worth, TX 76104-2717 Ph: (682) 885-8012 |
News Archive
Genoptix, Inc. today announced that it will participate in Aetna's (AET) national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.
Neogenix Oncology announced today that the U.S. Patent and Trade Mark Office has issued a Notice of Allowance for a patent application related to its 16C3 antibody. Discovered and developed by Neogenix Oncology, this antibody appears to have anti-tumor activity for both pancreatic and colorectal tumors, and may have both therapeutic and diagnostic utility. The antibody may have activity in other tumors as well, which the company will explore at such time as it prepares a pre-IND package for FDA review and designs a clinical trial for the 16C3 antibody.
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.
As the obesity epidemic grows in the United States, the medical community is faced with the significant challenge of properly treating patients before complications such as heart disease arise.
Researchers at the University of Missouri-Columbia can now detect the spread of skin cancer cells through the blood by literally listening to their sound.
› Verified 7 days ago
Dr. Heidi Danielle Tomlinson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Pennsylvania Ave, Department Of Neonatology, Fort Worth, TX 76104 Phone: 817-250-2892 | |
Rachel Marie Souers, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-6726 Fax: 682-885-6729 | |
Gregory Barker, Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1500 Cooper St, Fort Worth, TX 76104 Phone: 682-885-2140 Fax: 817-332-2506 | |
Anne Marcum Kirk, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-1475 Fax: 682-885-7520 | |
Khalid H Syed, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2332 Beverly Hills Dr, Fort Worth, TX 76114 Phone: 817-378-0855 Fax: 817-378-0861 | |
Dr. Phuong Thi Nguyen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-1475 Fax: 682-885-7520 |